Literature DB >> 31403596

Small-Group, Community-Member Intervention for Urinary and Bowel Incontinence: A Randomized Controlled Trial.

Heidi W Brown1, Emilie J Braun, Meg E Wise, Shannon Myers, Zhanhai Li, Emmanuel Sampene, Sierra M Jansen, D Paul Moberg, Jane E Mahoney, Rebecca G Rogers.   

Abstract

OBJECTIVE: To evaluate the effects of Mind Over Matter: Healthy Bowels, Healthy Bladder, a small-group intervention, on urinary and bowel incontinence symptoms among older women with incontinence.
METHODS: In this individually randomized group treatment trial, women aged 50 years and older with urinary, bowel incontinence, or both, were randomly allocated at baseline to participate in Mind Over Matter: Healthy Bowels, Healthy Bladder immediately (treatment group) or after final data collection (waitlist control group). The primary outcome was urinary incontinence (UI) improvement on the Patient Global Impression of Improvement at 4 months. Validated instruments assessed incontinence, self-efficacy, depression, and barriers to care-seeking. Intent-to-treat analyses compared differences between groups. Target sample size, based on an anticipated improvement rate of 45% in treated women vs 11% in the control group, 90% power, type I error of 0.05, with anticipated attrition of 25%, was 110.
RESULTS: Among 121 women randomized (62 treatment group; 59 control group), 116 (95%) completed the 4-month assessment. Most participants were non-Hispanic white (97%), with a mean age of 75 years (SD 9.2, range 51-98); 66% had attended some college. There were no significant between-group differences at baseline. At 4 months, 71% of treated women vs 23% of women in the control group reported improved UI on Patient Global Impression of Improvement (P<.001); 39% vs 5% were much improved (P<.001). Regarding bowel incontinence, 55% of treated women vs 27% of women in the control group improved on Patient Global Impression of Improvement (P<.005), with 35% vs 11% reporting much improvement (P<.005). Treated women improved significantly more than women in the control group on all validated instruments of incontinence severity, quality of life, and self-efficacy. Care-seeking rates were similar between groups.
CONCLUSION: Participation in a small-group intervention improves symptoms of both urinary and bowel incontinence in older women. Mind Over Matter is a feasible model with potential to bring effective behavioral solutions to the community. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT03140852.

Entities:  

Mesh:

Year:  2019        PMID: 31403596      PMCID: PMC6732187          DOI: 10.1097/AOG.0000000000003422

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.623


  28 in total

1.  St. Mark's incontinence score.

Authors:  Yasuko Maeda; Carolynne J Vaizey; Christine Norton
Journal:  Dis Colon Rectum       Date:  2007-09-27       Impact factor: 4.585

2.  A Randomized Controlled Trial to Compare 2 Scalable Interventions for Lower Urinary Tract Symptom Prevention: Main Outcomes of the TULIP Study.

Authors:  Carolyn M Sampselle; Diane K Newman; Janis M Miller; Keri Kirk; Mary Ann DiCamillo; Todd H Wagner; Trivellor E Raghunathan; Ananias C Diokno
Journal:  J Urol       Date:  2016-12-31       Impact factor: 7.450

3.  Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7).

Authors:  M D Barber; M D Walters; R C Bump
Journal:  Am J Obstet Gynecol       Date:  2005-07       Impact factor: 8.661

4.  Incontinence in older women.

Authors:  Patricia S Goode; Kathryn L Burgio; Holly E Richter; Alayne D Markland
Journal:  JAMA       Date:  2010-06-02       Impact factor: 56.272

5.  Validation of two global impression questionnaires for incontinence.

Authors:  Ilker Yalcin; Richard C Bump
Journal:  Am J Obstet Gynecol       Date:  2003-07       Impact factor: 8.661

6.  Factors associated with care seeking among women with accidental bowel leakage.

Authors:  Heidi W Brown; Steven D Wexner; Emily S Lukacz
Journal:  Female Pelvic Med Reconstr Surg       Date:  2013 Mar-Apr       Impact factor: 2.091

7.  Prevalence of incontinence among older americans.

Authors:  Yelena Gorina; Susan Schappert; Anita Bercovitz; Nazik Elgaddal; Ellen Kramarow
Journal:  Vital Health Stat 3       Date:  2014-06

8.  Mobile app for treatment of stress urinary incontinence: A randomized controlled trial.

Authors:  Ina Asklund; Emma Nyström; Malin Sjöström; Göran Umefjord; Hans Stenlund; Eva Samuelsson
Journal:  Neurourol Urodyn       Date:  2016-09-09       Impact factor: 2.696

9.  Prevention of urinary incontinence by behavioral modification program: a randomized, controlled trial among older women in the community.

Authors:  Ananias C Diokno; Carolyn M Sampselle; A Regula Herzog; T E Raghunathan; Sandra Hines; Kassandra L Messer; Cindy Karl; Maria Claudia A Leite
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

10.  Effectiveness of continence promotion for older women via community organisations: a cluster randomised trial.

Authors:  Cara Tannenbaum; Rona Agnew; Andrea Benedetti; Doneal Thomas; Eleanor van den Heuvel
Journal:  BMJ Open       Date:  2013-12-10       Impact factor: 2.692

View more
  3 in total

1.  Why Patients Fall Through the Cracks: Assessment of Patients' Overactive Bladder Treatment.

Authors:  Emily R W Davidson; Lia Miceli; Katie Propst
Journal:  J Womens Health (Larchmt)       Date:  2022-03-29       Impact factor: 3.017

2.  After the Randomized Trial: Implementation of Community-Based Continence Promotion in the Real World.

Authors:  Nicholas B Schmuhl; Katie A Brow; Meg E Wise; Shannon Myers; Jane E Mahoney; Heidi W Brown
Journal:  J Am Geriatr Soc       Date:  2020-08-17       Impact factor: 5.562

3.  Essential elements to "design for dissemination" within a research network-a modified Delphi study of the Community-Academic Aging Research Network (CAARN).

Authors:  Maria C Mora Pinzon; Shannon Myers; Jill Renken; Erin Eggert; Betty Chewning; Jane E Mahoney
Journal:  Implement Sci Commun       Date:  2021-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.